News
Keep up to date with our business activities by reading our news.
5 March 2025
Ascend Advanced Therapies Appoints John Chiminski as Chair & Karen Flynn as Independent Director
Rockville, MD – March 5, 2025 – Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner,...
Read More12 November 2024
Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities
London, United Kingdom – 12 November 2024 – Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with...
Read More4 October 2024
AST places next generation of flexible, isolated Fill-Finish system at Ascend Alachua facility for AAV production
The team is thrilled to partner with AST on a customized filling line that is being built for placement...
Read More24 September 2024
Continued Investment in Technology & Flexible Capacity, Including New Fill/Finish Capabilities, Fortify the Global Gene Therapy Support Offer at Ascend
London, United Kingdom – 24 September 2024 – Ascend Advanced Therapies (Ascend), a gene to GMP development partner, has...
Read More28 August 2024
Ascend Strengthens Operations with Two New Executive Team Hires
London, United Kingdom – 28 August 2024 – Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner has...
Read More24 April 2024
Ascend hires Scott Law as COO and continues strengthening foundation
London, United Kingdom, 24 April 2024 – Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner, has announced...
Read More9 April 2024
Ascend acquires GMP manufacturing capacity in Alachua, Florida from Beacon Therapeutics
London, United Kingdom, 9 April 2024 – Ascend Advanced Therapies (Ascend), an end-to-end gene therapy development partner, has acquired...
Read More27 March 2023
Mike Stella announced as the successor to founding CEO, Tim Funnell
Ascend Advanced Therapies launched out of stealth mode with a fundraise of over $130M in early 2023. Shortly thereafter,...
Read More20 March 2023
Ascend launches with over $130M of funding as expert teams merge
Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, potency, safety and cost...
Read More